5 months ago
SYK
AnalystsRobbie MarcusRobbie Marcus's Stock Forecasts
AnalystsRobbie Marcus
Analyst Ranking
Top 22%
#952 out of 4337 analysts
Average Return
+3.31%
Win Rate
49%22 out of 45
Risk vs Reward
Poor
Good
Robbie Marcus's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Conmed CorpCNMD | +102.61% | $65.64 | $132.99 | 2020-04-23 - 2021-04-23 | Strong Buy |
Inspire Medical Systems IncINSP | +94.81% | $128.00 | $249.36 | 2020-09-22 - 2021-09-20 | Strong Buy |
Minerva Surgical IncUTRS | +89.87% | $2.35 | $0.24 | 2022-08-10 - 2023-08-09 | Strong Sell |
Acutus Medical IncAFIB | +80.66% | $3.64 | $0.70 | 2021-11-12 - 2022-11-11 | Strong Sell |
Eargo IncEAR | +80.61% | $137.20 | $26.60 | 2021-09-23 - 2022-09-22 | Strong Sell |
Robbie Marcus Analyst Color
Get additional color on Robbie Marcus's coverage of popular stocks
5 months ago
ISRG
8 months ago
PEN
Robbie Marcus's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Insulet CorpPODD | 1 | Strong Buy | $325.00 | +110.12% | Maintains | 2 months ago |
Inogen IncINGN | 4 | Strong Sell | $8.00 | +55.64% | Downgrades | 2 months ago |
Nevro CorpNVRO | 3 | Hold | $23.00 | +21.31% | Maintains | 2 months ago |
Inspire Medical Systems IncINSP | 3 | Strong Buy | $340.00 | +83.71% | Maintains | 2 months ago |
Edwards Lifesciences CorpEW | 2 | Strong Buy | $100.00 | +43.97% | Maintains | 2 months ago |
Conmed CorpCNMD | 2 | Strong Buy | $145.00 | +42.18% | Maintains | 2 months ago |
Intuitive Surgical IncISRG | 3 | Strong Buy | $365.00 | +24.47% | Maintains | 2 months ago |
Silk Road Medical IncSILK | 1 | Hold | $28.00 | +74.56% | Downgrades | 2 months ago |
Integra Lifesciences Holdings CorpIART | 4 | Strong Sell | $43.00 | +12.24% | Downgrades | 4 months ago |
Stryker CorpSYK | 3 | Strong Buy | $315.00 | +9.61% | Maintains | 5 months ago |
Rxsight IncRXST | 2 | Strong Buy | $20.00 | -26.06% | Maintains | 7 months ago |
Bausch & Lomb CorpBLCO | 2 | Hold | $17.00 | -1.05% | Maintains | 7 months ago |
Boston Scientific CorpBSX | 2 | Strong Buy | $55.00 | +2.23% | Maintains | 8 months ago |
Penumbra IncPEN | 2 | Strong Buy | $285.00 | +15.31% | Maintains | 8 months ago |
Cvrx IncCVRX | 2 | Strong Buy | $18.00 | +24.74% | Maintains | 8 months ago |
Zimmer Biomet Holdings IncZBH | 1 | Hold | $17.60 | -85.00% | Maintains | 8 months ago |
Baxter International IncBAX | 4 | Hold | $55.00 | +46.67% | Downgrades | 9 months ago |
Bioventus IncBVS | 2 | Strong Sell | N/A | N/A | Downgrades | a year ago |
Abbott LaboratoriesABT | 5 | Strong Buy | $118.00 | +21.06% | Maintains | a year ago |
Minerva Surgical IncUTRS | 2 | Strong Sell | N/A | N/A | Downgrades | a year ago |
Zimvie IncZIMV | 1 | Hold | $20.00 | N/A | Initiates Coverage On | a year ago |
Medtronic PLCMDT | 2 | Hold | $105.00 | N/A | Downgrades | 2 years ago |
Irhythm Technologies IncIRTC | 1 | Strong Buy | $116.00 | N/A | Upgrades | 2 years ago |
Acutus Medical IncAFIB | 2 | Strong Sell | N/A | N/A | Downgrades | 2 years ago |
Eargo IncEAR | 2 | Strong Sell | $220.00 | N/A | Downgrades | 2 years ago |
Smiledirectclub IncSDC | 2 | Strong Sell | $6.00 | N/A | Downgrades | 2 years ago |
Treace Medical Concepts IncTMCI | 1 | Strong Buy | $37.00 | N/A | Initiates Coverage On | 2 years ago |
Neuropace IncNPCE | 1 | Strong Buy | $27.00 | N/A | Initiates Coverage On | 2 years ago |
Atricure IncATRC | 1 | Strong Buy | $81.00 | N/A | Maintains | 2 years ago |
Glaukos CorpGKOS | 1 | Hold | $55.00 | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.